Subscribe
type here...
Subscribe

Pharma & Biotecch

Fortunes of Indian pharmacos may get Trumped

Pharma & Biotecch Blitz Business Bureau -
US tariffs on Indian drugs may raise costs, cause shortages The United States' plan to impose a 25% tariff on Indian pharmaceutical imports is poised...

Safety pillfor pills – II

Pharma & Biotecch Blitz Business Bureau -
Drug rules being overhauled as per global standards While tightening drug safety regulations, the Government is also accelerating the approval process for life-saving medicines. Under...

Safety pillfor pills – I

Pharma & Biotecch Blitz Business Bureau -
Old drugs under review for quality control, efficacy The Government’s firm stance signals that even long-established drugs must now prove their safety and effectiveness under...

Active Production Imperative in-house

Pharma & Biotecch Blitz Business Bureau -
India’s success story in pharma is marredby excessive dependence on imported API Budget 2025 offers a critical opportunity to address these challenges and propel the...
spot_imgspot_img

Safety pillfor pills – I

Pharma & Biotecch Blitz Business Bureau -
Old drugs under review for quality control, efficacy The Government’s firm stance signals that even long-established drugs must now prove...

Active Production Imperative in-house

Pharma & Biotecch Blitz Business Bureau -
India’s success story in pharma is marredby excessive dependence on imported API Budget 2025 offers a critical opportunity to address...

A platform for change and progress. At Blitz India Business, our vision is to be a transformative platform that elevates the role of business and industry in driving India’s journey towards Viksit Bharat 2047. We are dedicated to fostering innovation, championing sustainability, and promoting inclusivity, while building a bridge for collaboration and progress.

News Categories

Quick Links

Get important news delivered directly to your inbox and stay connected!

© BlitzMedia Business